Vimarsana
Biggest News Aggregation in the World

Ron Renaud News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ron Renaud. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ron Renaud Today - Breaking & Trending Today

Upstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Team - Vimarsana News

Upstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Team

WALTHAM, Mass.--(BUSINESS WIRE)--Apr 2, 2024--

Abbvie buying biotech Cerevel - Vimarsana News

Abbvie buying biotech Cerevel

The deal comes less than a week after the Illinois-based pharmaceutical giant said it would acquire ImmunoGen of Waltham for more than $10 billion.

AbbVie Announces Acquisition of Cerevel Therapeutics Drugmaker for $8.7B - Vimarsana News

AbbVie Announces Acquisition of Cerevel Therapeutics Drugmaker for $8.7B

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

AbbVie to buy Cerevel for $8.7B, bolstering neuroscience portfolio - Vimarsana News

AbbVie to buy Cerevel for $8.7B, bolstering neuroscience portfolio

The $8.7 billion Cerevel pickup comes one week after AbbVie announced a $10.1 billion acquisition of ImmunoGen, a clinical-stage biotech.

Related Topics:
Ron RenaudRicharda Gonzalez
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline - Vimarsana News

AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline

Proposed acquisition adds robust pipeline of assets focused on best-in-class potential for psychiatric and neurological disorders where significant unmet needs...